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Abstract
Background: Alexander disease (AxD) is a rare neurological disease, especially in adults. It shows variable clinical
and radiological features.
Case presentation: We diagnosed a female with AxD presenting with paroxysmal numbness of the limbs at the
onset age of 28-year-old, progressing gradually to spastic paraparesis at age 30. One year later, she had ataxia,
bulbar paralysis, bowel and bladder urgency. Her mother had a similar neurological symptoms and died within
2 years after onset (at the age of 47), and her maternal aunt also had similar but mild symptoms at the onset age
of 54-year-old. Her brain magnetic resonance imaging (MRI) showed abnormal signals in periventricular white
matter with severe atrophy in the medulla oblongata and thoracic spinal cord, and mild atrophy in cervical spinal
cord, which is unusual in the adult form of AxD. She and her daughter’s glial fibrillary acidic protein (GFAP) gene
analysis revealed the same heterozygous missense mutation, c.1246C > T, p.R416W, despite of no neurological
symptoms in her daughter.
Conclusions: Our case report enriches the understanding of the familial adult AxD. Genetic analysis is necessary
when patients have the above mentioned symptoms and signs, MRI findings, especially with family history.
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Background
Alexander disease (AxD, OMIM 203450) is a rare but
fatal central nervous system disease. Three subtypes are
distinguished upon the onset age: infantile (under age 2),
juvenile (age 2 to 12) and adult (over age 12). The in-
fantile form is the most common subtype while the adult
onset the least. All subtypes have been described and
present with different clinical manifestations. However,
the pathological hallmark of the disease is the accumula-
tion of ubiquitinated intracytoplasmic inclusions in as-
trocytes, called rosenthal fibers, which are composed of
glial fibrillary acidic protein (GFAP), the main intermedi-
ate filament of astrocytes [1].
The adult cases can be distinguished in familial or
sporadic form. Here, we present a case of adult onset
AxD with family pedigree.
Case presentation
A 34-year-old female was evaluated at our hospital with
a 6-year history of progressive neurological symptoms.
At age 28, she developed paroxysmal numbness in the
left limbs, and two years later she had unilateral limb
weakness. She was misdiagnosed as multiple sclerosis at
the other hospital 2 years after onset. After high-dose
pulse methylprednisolone therapy, the illness had no
mitigation. The above mentioned symptoms progres-
sively worsened. At age 31, she subsequently developed
ataxia, dysarthria, depression, and bowel and bladder ur-
gency with occasional incontinence. And her hands be-
came mild muscle atrophy one year later.
She denied any medical history before. Her mother
had a similar neurological symptoms and died within
2 years after onset (at the age of 47), and her maternal
aunt also had similar but mild symptoms at the onset
age of 54 years old. Her 8-year-old daughter didn’t
present with any neurological symptoms but had brain
lesions. Other family members were healthy (Fig. 1).
Her general medical examination was unremarkable.
In neurological examination, she had normal mental
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status and language testing. The mixed spastic-ataxic dys-
arthria and horizontal gaze nystagmus were noted. Myo-
kymia was observed in lingualis with weakness of bulbar
muscles. Her hands showed mild muscular atrophy. The
muscles strength of the bilateral upper-extremities, the left
lower-extremity, the right lower-extremity were grade 4, 2,
1, respectively. The increased tendon reflexes and the
positive Babinski signs were observed bilaterally. Ataxia
was observed in bilateral upper limbs. There was no ap-
parent sensory deficit or extrapyramidal signs. The latest
score of modified Rankin scale is 4.
Serum laboratory studies showed unremarkable
(complete blood count, routine chemistry test, clotting
studies, electrolyte panel, creatinine, glucose, liver and
renal function tests, vitamin B12, vitamin E, folic acid,
autoimmune antibodies, and infection including hepatitis
virus antibodies, Treponema serology, HIV antibodies).
Cerebrospinal fluid examination showed a normal open-
ing pressure, the cell count, protein, glucose, IgG index,
anti-aquaporin-4 antibody, and intrathecal IgG synthesis
rate without oligoclonal bands.
Electroencephalogram, electrophysiological, visual
evoked potential, as well as all of the autonomic nervous
system testing were all normal 2 years after onset except
aural conduction in their brainstem evoked potential.
Her brain MRI demonstrated bilateral and symmetric
abnormal signals without gadolinium enhancement, which
were predominantly distributed in the periventricular, and
subcortical white matter. Diffusion Weighted Imaging
(DWI) revealed slightly hyperintensity in the periventricu-
lar areas. Magnetic resonance angiography was normal
[Fig. 2]. The marked atrophy of the medullary oblongata
and thoracic spinal cord was seen, while the atrophy of
cervical spinal cord was relatively mild. Abnormal T2
hyperintensity was noted in the pyramidal tract of spine.
With symptoms progressively worsening, medullary and
cerebellar atrophy accelerated [Fig. 3]. Her daughter brain
MRI showed abnormality in the periventricular white
matter [Fig. 4].
Her genomic DNA was extracted from the peripheral
leucocytes when an informed consent was obtained from
the patient and her husband. A heterogeneous missense
mutation was detected in exon 8 (c.1246C > T) of the
GFAP gene, causing a change of arginine to tryptophan
Fig. 1 Family pedigree. Black filled symbols represent patients. Grey
filled symbols refer to patient’s daughter who had GFAP mutations
but without neurological signs or symptoms. Empty symbols
represent healthy subjects. Half-filled symbols refer to presumably
affected ancestor. Question marks mean subjects potentially affected
without neurological signs or symptoms, not examined nor tested
for GFAP mutations. Oblique slash means the deceased. Black arrow
mark represents the propositus (our patient). Patient III-3 and her
daughter (patient IV-4) performed the molecular diagnosis. Although
the family member (II-1) had similar psychological manifestations,
the detailed medical record was not obtained and not examined for
GFAP mutations
Fig. 2 Axial Brain MRI showed low T1-weighted signals (a), high T2-weighted signals (b), and hyperintensity in FLAIR image(c) around the periven-
tricular area. MRI with contrast enhancement was normal (d). DWI revealed slight hyperintensity (e). MRA were normal (f)
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at amino acid position 416 (p.R416W). Her daughter’s
genomic DNA showed the same heterozygous mutation
but without any neurological symptoms [Fig. 5]. Upon
clinical, family history, MRI finding and gene analysis,
she was confirmed as adult AxD.
This case with AxD is characterized by typical clinical
and MRI findings, especially with family history and
adult onset. The heterozygous missense mutation in the
GFAP gene, c.1246C > T, p.R416W was identified, which
was already shown to be pathogenic in adult onset AxD
[2, 3]. It has been reported that adult AxD has various
clinical courses. Most cases have a subacute onset and
gradually progressive course [2], but some present an
acute onset [4]. There is no gender difference. About
half of the cases is familial, consistent with autosomal
dominant transmission. The mean age of onset is usually
in the late thirties. Our patient had pseudobulbar, spastic
paresis and ataxia, which are acknowledged as the
cardinal triad of the clinical presentations and appear in
approximately 70 % of cases [2, 4, 5]. Palatal myoclonus,
which is specific and essential for AxD diagnosis, is only
observed in one third, especially in hereditary cases [6],
not seen in our patient. Nearly 45 % of reported patients
had autonomic dysfunction including bowel/bladder
dysfunction and orthostatic hypotension [7], which was
found in our patient.
Typical MRI findings included marked signal periven-
tricular changes, atrophy of the bulbar region and upper
cervical spinal cord in adult AxD [2, 7]. Approximately
Fig. 3 Axial spinal MRI showed hyperintensity involving the corticospinal tracts extends from the carotid 2 (a arrowhead) to carotid 7 cord (b
arrowhead) in T2WI image, mild atrophy of cervical spinal cord in sagittal T1WI image (c), severe atrophy of whole thoracic segments in sagittal
T2WI image, which is similar to the typical “tadpole” (d), medullary atrophy at 3 years after onset (e, f), and severe medulla and cerebellar atrophy
1 years later (g, h)
Fig. 4 Axial FLAIR image of the asymptomatic daughter of our
patient show band-like hyperintense lesions around the
lateral ventricle
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90 % cases showed marked medullary atrophy and 50 %
had deep white matter lesions or periventricular changes
[5]. Farina et al. reported that patients under 40 years
old were easier to have periventricular white matter ab-
normalities and postcontrast enhancement than patients
over 40, which showed different levels of abnormal diffu-
sivity On DWI, but some cases were normal [8]. In our
case, MRI findings showed the severe atrophy in bulbar
region and thoracic spinal cord, but mild atrophy in cer-
vical spinal cord, which is rare in the adult AxD. On
DWI, our patient had slightly hyperintensity of extensive
periventricular white matter. The lesions without gado-
linium enhancement might be related to the decreased
amounts and limited distribution of rosenthal fibers [8].
It should be stressed that MRI findings in our case was
atypical despite of the lesion locating in the typical
regions.
In the radiologic differential diagnosis of adult AxD, sev-
eral disorders need to be considered [9]. Diseases like de-
generative disorders, particularly progressive supranuclear
palsy, multisystem atrophy with cerebellar predominance,
and various spinocerebellar ataxias often have brain stem
and cerebellum atrophy but without lesions in pe-
riventricular white matter [8]. Besiedes, some leukodystro-
phies which are similar to adult AxD were described
below (see Table 1) [5, 10–17].
Beside, asymptomatic carriers with MRI abnormalities
have been described in some reports [2, 6, 8, 18–23].
Here we listed several asymptomatic carriers similar to
Fig. 5 The chromatograms of sequencing results. a The patient. b
The daughter. c The control. In the area of the GFAP gene exon 8,
there is a heterogeneous missense mutation point: c.1246C > T
(cytosine > thymine, Aarrowhead), leading to amino acid change in
p.R416W (arginine > tryptophan)
Table 1 The characteristics of common leukodystrophies in adult
Disease Clinical presentation Abnormal regions or abnormalities on brain MRI Gene
mutations
X-ALD SP CST, dorsal columns, CC, PWM ABCD1
Metachromatic
leukodystrophy
PP, motor impairment bilateral frontal PWM, CC; cortical atrophy ARSA
Krabbe’s disease (GALC) SP or tetraparesis, PDPN, CD, seizures,
cortical blindness
Supratentorial, CWM, PT, splenium of CC and optic radiation,
CST; CC atrophy
GALC
VWM (CACH) migraine, PP, dementia, PBP, SP enlargement of the lateral ventricles; WM EIF2B
HDLS/POLD behavioral changes, dementia, motor
impairment, epilepsy
internal capsules, CST; WM with non-enhancing; frontal lobes
atrophy
CSF1R
ADLD AS, BBD, OH, PS, ataxia frontoparietal WM, CP, CST, CC LMNB1
Cerebrotendinous
xanthomatosis
PP, SP, CA, polyneuropathy, tendon
xanthomatas
dentate nucleus, CWM, CP, PT, PWN, CC, basal ganglia; brain
and cerebellar atrophy
CYP27A1
NHD/PLOSL PP, memory loss, dementia, skeletal
abnormalities
nonspecific WM; cortical atrophy TREM2
DAP12
CADASIL migraines, TIA, strokes, PP, CD PWM in the centrum semiovale, external capsules and anterior
temporal poles
NOTCH3
CARASIL TIA, strokes diffuse WM changes, lacunar infarcts HTRA1
X-ALD X-linked adrenoleukodystrophy, VWM Vanishing white matter disease, CACH childhood ataxia with central hypomylination, HDLS hereditary diffuse
leukoencephalopathy with neuroaxonal spheroids, POLD Autosomal dominant pigmentary type of orthochromatic leucodystrophy, ADLD Adult-onset autosomal
dominant leukodystrophy, NHD Nasu-Hakola disease, PLOSL polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy, SP spastic paraparesis, PP
psychiatric problems, PBP pseudobulbar palsy, WM white matter, CWM cerebellar WM, PT pyramidal tracts, CD cognitive decline, AS autonomic symptoms, BBD bowel
and bladder dysfunction, OH orthostatic hypotension, PS pyramidal symptoms, CA cerebellar ataxia, TIA transient ischemic attacks, PDPN peripheral demyelinating
polyneuropathy, CST corticospinal tracts, CC corpus callosum, PWM periventricular WM, CP cerebellar peduncles
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our patient’s daughter who had abnormal brain MRI and
carrying the gene mutation (see Table 2).
Mutations in the GFAP gene, which lead to the accumu-
lation of ubiquitinated intracytoplasmic inclusions in
rosenthal fibers in association with the small heat shock
proteins, HSP27 and aB-crystallin [1], are thought to ac-
count for more than 95 % of AxD cases [24]. In infantile
[3, 25, 26], juvenile [20, 27] and sporadic adult AxD
[28–30], the heterozygous missense mutation of the GFAP
gene, c.1246C > T, p.R416W, has been reported to be one
of the causes of AxD. While In familial adult onset AxD it
has been rarely reported. Thyagarajan described a woman
and her son with adult onset AxD and the above mutation
[31]. They had different clinical manifestations but strik-
ingly similar MRI abnormalities and the same GFAP mu-
tation. It means that molecularly characterized inherited
AxD is a cause of symptoms. The same GFAP mutation
can cause both early and late onset AxD, and vertical
transmission occurs in adult onset AxD with GFAP muta-
tions. Our patient, her mother and maternal aunt had
similar neurological manifestations but the latter two had
a relative later onset. Nevertheless, her mother’s clinical
manifestations deteriorated rapidly, her maternal aunt has
mild symptoms with comparatively slow progress. She
and her daughter had the same heterozygous missense
mutation. All these findings suggest that the familial Adult
AxD members can possibly show either similar or differ-
ent manifestations. The molecular genetic evidence of our
AxD family favors that AxD is an autosomal dominant in-
heritance [32], but further long-term follow-up is needed.
Conclusions
In summary, our case report enriches the understanding
of the familial adult AxD. Genetic analysis is necessary
when patients have the above mentioned symptoms and
signs, MRI findings, especially with family history.
Abbreviations
AxD: Alexander disease; DNA: Deoxyribonucleic acid; DWI: Diffusion
Weighted Imaging; FLAIR: Fluid attenuated inversion recovery; GFAP: Glial
fibrillary acidic protein; HIV: Human immunodeficiency virus; MRA: Magnetic
resonance angiography; MRI: Magnetic resonance imaging; T1WI: T1-
weighted imaging; T2WI: T2-weighted imaging
Acknowledgements
The authors would like to thank the patient’s family and the Beijing JinZhun
Gene Technology Co., Ltd. The work couldn’t be done without their
participation and help.
Funding
We receive no funding support.
Availability of data and materials
Not applicable. For protecting patient privacy.
Authors’ contributions
Study design and drafting of manuscript: YL, XZ. Clinical study perform: YL,
XZ, HZ. Genetic analysis: HZ, HW. Acquisition and interpretation of data: YL,
XG, AZ, LZ, XL. Critical revision of the manuscript: XH, HW, YL. All authors
have read and approved the final manuscript.
Competing interest
The authors declare that they have no competing interests.
Consent for publication
Written informed consents were obtained from the patient for publication of
this case report and any accompanying images. A copy of the written
consent is available for review by the Editor of this journal.
Table 2 The information of asymptomatic carriers with MRI abnormalities
Patient Reference Gender Age (years) MRI scan Nucleotide change Aminoacid
substitution
Patient 1 [18] Male 62 Mild cervicomedullary atrophy c.232G > A p.D78N
Patient 2 [6] Male 32 Atrophy of medulla oblongata and spinal
cord, Periventricular rim
c. 274 T > G p.V87G
Patient 3 [19] Male 33 Atrophy of medulla oblongata and spinal
cord, white matter lesion, periventricular rim
c. 274 T > G p.V87G
Patient 4 [20] Male a<4 Frontal white matter abnormality c.276C > T p.R88C
Patient 5 [2] Male 30 Supratentorial periventricular white matter,
atrophy of medulla oblongata and cervical cord
c.613G > A p.E205K
Patient 6 [21] Male 32 Periventricular rim, atrophy of medulla c.988C > G p.R330G
c.994G > A p.E332K
Patient 7 [22] Female 34 Mild abnormal intensities in the deep frontal
white matter and caudates
c.1006 T > C p.L331P
Patient 8 [23] Male 72 Atrophy of the upper cervical cord medullaoblongata
and cerebellar
c.1157A > G p.N386S
Patient 9 [8] Male 52 Supratentorial periventricular white matter, atrophy
of medulla oblongata and cervical cord
c. 1193C > A p.S398Y
Patient 10 [20] Male a<11 White matter of the cerebellum, medulla, pons changes c.1260C > T p.R416W
c.154C > T p.P47L
aNo age at onset is reported for Patients 4 and 10; evaluation for leukodystrophy was initiated only after incidental findings of white matter changes were
discovered by MRI performed as part of examination for other conditions
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